D.A. Davidson & Co’s Annovis Bio ANVS Stock Holding History

D.A. Davidson & Co’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-160,779	Closed	-$556K	–	1570
2025 Q4	$556K	Buy	+160,779	New	+$483K	﹤0.01%	1106

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

D.A. Davidson & Co's ANVS Position: Q1 2026 in Review

D.A. Davidson & Co sold out of Annovis Bio (ANVS) in Q1 2026, closing a stake of 160,779 shares — an estimated $556K sold.

D.A. Davidson & Co first reported a position in ANVS in Q4 2025 and held it in 1 quarter. The position peaked at $556K in Q4 2025. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

D.A. Davidson & Co reported no remaining Annovis Bio position as of Q1 2026 after selling out during the quarter.
D.A. Davidson & Co sold 160,779 Annovis Bio shares in Q1 2026, an estimated $556K.
D.A. Davidson & Co first reported a position in Annovis Bio in Q4 2025 and held it in 1 quarter.
D.A. Davidson & Co's Annovis Bio position peaked at $556K in Q4 2025.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.